AADI News and Press, Aadi Bioscience Inc.

Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update PR Newswire MORRISTOWN, N.J. , March 14, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi") today announced that it will host a webcast to discuss fourth...

Portage Biotech Inc. (PRTG) is expected to report for Q3 2025 Aimei Health Technology Co. Ltd (AFJK) is expected to report for quarter end 2024-12-31 Generation Bio Co. (GBIO) is expected to report $-0.28 for Q4 2024 TAT Technologies Ltd. (TATT) is expected to report for quarter end 2...

Aadi Bioscience Announces Closing of $100 Million PIPE Financing PR Newswire MORRISTOWN, N.J. , March 4, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi"), an oncology therapeutics company applying advanced technologies to established tumor biolo...

Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders PR Newswire MORRISTOWN, N.J. , March 3, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), an oncology therapeutics company applying advanced technologies to establishe...

Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference PR Newswire MORRISTOWN, N.J. , Feb. 24, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI) announced today its presentation at the TD Cowen 45 th Annual Healthc...

Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer PR Newswire Seasoned Oncology Leader Brings Extensive ADC Expertise to Support Company's New Pipeline MORRISTOWN, N.J. , Feb. 18, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: A...

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025 PR Newswire Proxy Statement Includes Proposals on Previously Announced Sale of FYARRO and Associated Infrastructure to Kaken for $100M , and $100M PIPE Fi...